Therapeutic targets for HIV-1 infection in the host proteome

BACKGROUND: Despite the success of HAART, patients often stop treatment due to the inception of side effects. Furthermore, viral resistance often develops, making one or more of the drugs ineffective. Identification of novel targets for therapy that may not develop resistance is sorely needed. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Winnie S, Maddukuri, Anil, Teslovich, Tanya M, de la Fuente, Cynthia, Agbottah, Emmanuel, Dadgar, Shabnam, Kehn, Kylene, Hautaniemi, Sampsa, Pumfery, Anne, Stephan, Dietrich A, Kashanchi, Fatah
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087880/
https://www.ncbi.nlm.nih.gov/pubmed/15780141
http://dx.doi.org/10.1186/1742-4690-2-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087880/
https://www.ncbi.nlm.nih.gov/pubmed/15780141
http://dx.doi.org/10.1186/1742-4690-2-20

Ejemplares similares